Home › Funds › Royce & Associates › CCCC
Royce & Associates position in CCCC
C4 THERAPEUTICS INC · Health Care
Latest position (Q1 2024)23.60K sh
Reported value held$192.84K
Portfolio Weight0.00%
First reportedQ4 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 42.55K | $240.43K | New |
| Q1 2024 | 23.60K | $192.84K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CCCC
- Morgan Stanley 8.87M sh · $41.41M · Q2 2026
- BlackRock Inc 7.90M sh · $36.88M · Q2 2026
- JPMorgan Chase & Co 4.75M sh · $20.65M · Q2 2026
- Citadel Advisors 4.28M sh · $20.01M · Q2 2026
- Goldman Sachs Group 3.53M sh · $16.49M · Q2 2026
- Two Sigma Investments 3.47M sh · $16.20M · Q2 2026
- Bank of America Corp 2.66M sh · $12.41M · Q2 2026
- Geode Capital Management 2.52M sh · $11.78M · Q2 2026
- Vanguard Group 4.38M sh · $8.37M · Q4 2025
- D. E. Shaw & Co 1.74M sh · $8.13M · Q2 2026
- Renaissance Technologies 1.19M sh · $5.56M · Q2 2026
- Northern Trust Corp 1.16M sh · $5.42M · Q2 2026